Retinol-binding protein 4: A novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus

Journal of Perinatal Medicine

Volumn 38, Issue 2, 2010, Pages 147-155

  Mazaki Tovi, Shali ^a,b   Romero, Roberto ^a,b   Vaisbuch, Edi ^a,b   Kusanovic, Juan Pedro ^a,b   Chaiworapongsa, Tinnakorn ^a,b   Kim, Sun Kwon ^a   Mittal, Pooja ^a,b   Dong, Zhong ^a   Pacora, Percy ^a   Yeo, Lami ^a,b   Hassan, Sonia S ^a,b  

^a HUTZEL HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipokine; Adipose tissue; Appropriate for gestational age (AGA); Body mass index (BMI); Cytokine; Insulin resistance; Insulin sensitivity; Metabolism; Obesity; Overweight; Pregnancy

Indexed keywords

CARBOHYDRATE; RETINOL BINDING PROTEIN 4;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARBOHYDRATE INTOLERANCE; CONTROLLED STUDY; DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HUMAN; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; MATERNAL PLASMA; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; FETAL MACROSOMIA; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MATERNAL AGE; PREGNANCY; RETINOL-BINDING PROTEINS, PLASMA; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 77749289234     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2010.044     Document Type: Article

References (104)

1. From the NIH: successful diet and exercise therapy is conducted in Vermont for "diabesity". J Am Med Assoc. 1980;243:519-20.
2. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser. 2003;916:i-149, backcover.
3. Prevention of diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser. 1994;844:1-100.
4. Aeberli I, Biebinger R, Lehmann R, L'allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocr Metab. 2007;92:4359-65.
5. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocr Metab. 2007;92:1971-4.
6. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21:103-13.
7. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocr Metab. 2001;86:989-93.
8. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115:485-91.
9. Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK. Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes. Diabetes. 1999;48: 2430-6.
10. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768-73.
11. Catalano PM, Bernstein IM, Wolfe RR, Srikanta S, Tyzbir E, Sims EA. Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol. 1986;155:1255-62.
12. Catalano PM, Kirwan JP. Clinical utility and approaches for estimating insulin sensitivity in pregnancy. Semin Perinatol. 2002;26:181-9.
13. Catalano PM, Kirwan JP, Haugel-de MS, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr. 2003; 133:1674S-83S.
14. Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol. 1991;165:914-9.
15. Chan TF, Chen HS, Chen YC, Lee CH, Chou FH, Chen IJ, et al. Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci. 2007;14:169-74.
16. Choi SH, Kwak SH, Youn BS, Lim S, Park YJ, Lee H, et al. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocr Metab. 2008;93:3142-8.
17. Coustan DR, Carpenter MW, O'Sullivan PS, Carr SR. Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol. 1993;168:1139-44.
18. Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol. 1989; 73:557-61.
19. Craig RL, Chu WS, Elbein SC. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol Genet Metab. 2007;90:338-44.
20. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881-7.
21. Ecker JL, Greenberg JA, Norwitz ER, Nadel AS, Repke JT. Birth weight as a predictor of brachial plexus injury. Obstet Gynecol. 1997;89:643-7.
22. Ellard S, Beards F, Allen LI, Shepherd M, Ballantyne E, Harvey R, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia. 2000;43:250-3.
23. Farvid MS, Ng TW, Chan DC, Barrett PH, Watts GF. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab. 2005;7:406-13.
24. Gabbe SG. Gestational diabetes mellitus. N Engl J Med. 1986;315:1025-6.
25. Garvey WT, Maianu L, Zhu JH, Hancock JA, Golichowski AM. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters. Diabetes. 1993;42:1773-85.
26. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocr Metab. 2004;89:2563-8.
27. Gonzalez RP, Gomez RM, Castro RS, Nien JK, Merino PO, Etchegaray AB, et al. [A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. Rev Med Chil. 2004;132:1155-65.
28. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354:2552-63.
29. Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, et al. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Eur J Endocrinol. 2007; 157:201-7.
30. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocr Metab. 2007;92:1168-71.
31. Homko C, Sivan E, Chen X, Reece EA, Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocr Metab. 2001;86: 568-73.
32. Ingelsson E, Lind L. Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care. 2009;32:733-5.
33. Inoue S, Takamoto N, Akahori Y, Masumoto A, Nakatsukasa H, Msuyama H, et al. Elevated level of serum retinolbinding protein 4 in pregnancy-induced hypertension. J Obstet Gynaecol Res. 2009;35:293-300.
34. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840-6.
35. Kaufmann RC, McBride P, Amankwah KS, Huffman DG. The effect of minor degrees of glucose intolerance on the incidence of neonatal macrosomia. Obstet Gynecol. 1992; 80:97-101.
36. Khine ML, Winklestein A, Copel JA. Selective screening for gestational diabetes mellitus in adolescent pregnancies. Obstet Gynecol. 1999;93:738-42.
37. Kim SH, Choi HJ, Im JA. Retinol-binding protein 4 responses during an oral glucose tolerance testing in women with gestational diabetes mellitus. Clin Chim Acta. 2008; 391:123-5.
38. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862-8.
39. Krzyzanowska K, Zemany L, Krugluger W, Schernthaner GH, Mittermayer F, Schnack C, et al. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia. 2008;51:1115-22.
40. Kusanovic JP, Romero R, Mazaki-Tovi S, Chaiworapongsa T, Mittal P, Gotsch F, et al. Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation. J Matern Fetal Neonat Med. 2008;21:902-16.
41. Langer O, Anyaegbunam A, Brustman L, Divon M. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol. 1989;161:593-9.
42. Langer O, Anyaegbunam A, Brustman L, Guidetti D, Mazze R. Gestational diabetes: insulin requirements in pregnancy. Am J Obstet Gynecol. 1987;157:669-75.
43. Laudes M, Oberhauser F, Bilkovski R, Schubert M, Udel-hoven M, Wassmer G, et al. Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity. Exp Clin Endocr Diab. 2009; 117:146-9.
44. Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ, et al. Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet Med. 2005;22:569-75.
45. Lee JW, Lee HR, Shim JY, Im JA, Lee DC. Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects. Endocr J. 2008;55:811-8.
46. Leikin EL, Jenkins JH, Pomerantz GA, Klein L. Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomia. Obstet Gynecol. 1987;69:570-3.
47. Lewandowski KC, Stojanovic N, Bienkiewicz M, Tan BK, Prelevic GM, Press M, et al. Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol. 2008;24:300-5.
48. Mauricio D, de Levia A. Autoimmune gestational diabetes mellitus: a distinct clinical entity? Diabetes Metab Res Rev. 2001;17:422-8.
49. Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Efraty Y, Schiff E, et al. Determining the source of fetal adiponectin. J Reprod Med. 2007;52:774-8.
50. Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Schiff E, Sivan E. Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol. 2005;193:1238-42.
51. Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Wiser A, Schiff E, et al. Maternal serum adiponectin levels during human pregnancy. J Perinatol. 2007;27:77-81.
52. Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Yinon Y, Wiser A, et al. Adiponectin and leptin concentrations in dichorionic twins with discordant and concordant growth. J Clin Endocr Metab. 2009;94:892-8.
53. Mazaki-Tovi S, Kanety H, Sivan E. Adiponectin and human pregnancy. Curr Diab Rep. 2005;5:278-81.
54. Mazaki-Tovi S, Romero R, Kim SK, Vaisbuch E, Kusanovi JP, Erez O, et al. Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA? J Matern Fetal Neonat Med. 2009; PMID 19900033.
55. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Gotsch F, Mittal P, et al. Visfatin/pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition. J Perinat Med. 2008;36:485-96.
56. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Vaisbuch E, Gotsch F, et al. Adiponectin multimers in maternal plasma. J Matern Fetal Neonat Med. 2008;21:796-815.
57. Mazaki-Tovi S, Romero R, Kusanovic JP, Vaisbuch E, Erez O, Than NG, et al. Maternal visfatin concentration in normal pregnancy. J Perinat Med. 2009;37:206-17.
58. Mazaki-Tovi S, Romero R, Kusanovic JP, Vaisbuch E, Erez O, Than NG, et al. Visfatin in human pregnancy: maternal gestational diabetes vis-a-vis neonatal birthweight. J Perinat Med. 2009;37:218-31.
59. Mazaki-Tovi S, Romero R, Vaisbuch E, Chaiworapongsa T, Erez O, Mittal P, et al. Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection. J Perinat Med. 2009;DOI: 10.1515/JPM.2009.134.
60. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Chaiwa-ropongsa T, Mittal P, et al. Maternal plasma visfatin in preterm labor. J Matern Fetal Neonat Med. 2009;22:693-704.
61. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiwaropongsa T, et al. Dysregulation of maternal serum adiponectin in preterm labor. J Matern Fetal Neonat Med. 2009;22:887-904.
62. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiwaropongsa T, et al. Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med. 2009;DOI: 10.1515/JPM.2009.101.
63. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiwaropongsa T, et al. Maternal serum adiponectin multimers in patients with a small-for-gestational-age newborn. J Perinat Med. 2009;DOI: 10.1515/JPM.2009. 128.
64. Mazaki-Tovi S, Romero R, Vaisbuch E, Kusanovic JP, Erez O, Gotsch F, et al. Maternal serum adiponectin multimers in preeclampsia. J Perinat Med. 2009;37:349-63.
65. Mazaki-Tovi S, Romero R, Vaisbuch E, Kusanovic JP, Erez O, Mittal P, et al. Adiponectin in amniotic fluid in normal pregnancy, spontaneous labor at term, and preterm labor: a novel association with subclinical intrauterine infection/inflammation. J Matern Fetal Neonat Med. 2009;DOI: 10.1080/14767050903026481.
66. Metzger BE, Cho NH, Roston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care. 1993;16:1598-605.
67. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop - Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(Suppl 2):B161-7.
68. Mills JP, Furr HC, Tanumihardjo SA. Retinol to retinol-binding protein (RBP) is low in obese adults due to elevated apo-RBP. Exp Biol Med (Maywood). 2008;233:1255-61.
69. Munkhtulga L, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, Omi T, et al. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum Genet. 2007;120:879-88.
70. Muoio DM, Newgard CB. Metabolism: a is for adipokine. Nature. 2005;436:337-8.
71. Nien JK, Mazaki-Tovi S, Romero R, Erez O, Kusanovic JP, Gotsch F, et al. Adiponectin in severe preeclampsia. J Perinat Med. 2007;35:503-12.
72. Nien JK, Mazaki-Tovi S, Romero R, Erez O, Kusanovic JP, Gotsch F, et al. Plasma adiponectin concentrations in nonpregnant, normal and overweight pregnant women. J Perinat Med. 2007;35:522-31.
73. Nien JK, Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Gotsch F, et al. Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J Perinat Med. 2007;35:513-21.
74. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, et al. Adiponectin reduces atherosclerosis in apoli-poprotein E-deficient mice. Circulation. 2002;106:2767-70.
75. Okuno S, Akazawa S, Yasuhi I, Kawasaki E, Matsumoto K, Yamasaki H, et al. Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy. Horm Metab Res. 1995;27:231-4.
76. O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278-85.
77. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473-6.
78. Polonsky KS. Retinol-binding protein 4, insulin resistance, and type 2 diabetes. N Engl J Med. 2006;354:2596-8.
79. Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocr Metab. 2007;92:4827-34.
80. Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P. Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes. 2009;58:54-60.
81. Romero R. The child is the father of the man. Prenat Neonat Med. 1996;1:8-11.
82. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444: 847-53.
83. Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, et al. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes. 1995;44:506-12.
84. Saker PJ, Hattersley AT, Barrow B, Hammersley MS, McLellan JA, Lo YM, et al. High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia. 1996;39:1325-8.
85. Sell H, Eckel J. Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha. Diabetologia. 2007;50:2221-3.
86. Shangguan X, Liu F, Wang H, He J, Dong M. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia. Clin Chim Acta. 2009;407:58-61.
87. Shepherd PR, Kahn BB. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999;341:248-57.
88. Sivan E, Mazaki-Tovi S, Pariente C, Efraty Y, Schiff E, Hemi R, et al. Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocr Metab. 2003; 88:5656-60.
89. Sklan D, Shalit I, Lasebnik N, Spirer Z, Weisman Y. Retinol transport proteins and concentrations in human amniotic fluid, placenta, and fetal and maternal sera. Br J Nutr. 1985;54:577-83.
90. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104:531-43.
91. Stepan H, Ebert T, Schrey S, Reisenbuchler C, Bluher M, Stumvoll M, et al. Preliminary report: serum levels of retinol-binding protein 4 in preeclampsia. Metabolism. 2009;58:275-7.
92. Takahashi YI, Smith JE, Goodman DS. Vitamin A and retinol-binding protein metabolism during fetal development in the rat. Am J Physiol. 1977;233:E263-72.
93. Tamori Y, Sakaue H, Kasuga M. RBP4, an unexpected adipokine. Nat Med. 2006;12:30-1.
94. Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocr Metab. 2007;92:2764-72.
95. Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, et al. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring). 2008;16:2439-44.
96. Ueland T, Dalsoren T, Voldner N, Godang K, Henriksen T, Bollerslev J. Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies. Eur J Endocrinol. 2008;159:49-54.
97. Vaisbuch E, Mazaki-Tovi S, Kusanovic JP, Erez O, Than GN, Kim SK, et al. Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation. J Matern Fetal Neonat Med. 2009; PMID 19900011.
98. Vaisbuch E, Romero R, Mazaki-Tovi S, Erez O, Kim SK, Chaiworapongsa T, et al. Retinol binding protein 4 - a novel association with early-onset preeclampsia. J Perinat Med. 2009;DOI: 10.1515/JPM.2009.140.
99. von EM, Humpert PM. Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Rev Mol Diagn. 2008;8:289-99.
100. von Eyhatten M, Lepper PM, Liu D, Lang K, Baumann M, Nawroth PP, et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia. 2007;50:1930-7.
101. Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes. 1999;48: 848-54.
102. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436:356-62.
103. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocr Metab. 2007;92:2590-7.
104. Yogev Y, Langer O, Xenakis EM, Rosenn B. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonat Med. 2005;17:29-34.